Kinfo
Barinthus Biotherapeutics Pte Ltd. logo

Barinthus Biotherapeutics Pte Ltd.

BRNSNASDAQHealthcare·US · USD
$0.56
-0.04 (-6.16%)
Prices as of August 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap24.47M USD
Enterprise value-31.69M USD
Trailing P/E-0.36
Forward P/E-0.52
PEG ratio0.01
Price / sales0.00
Price / book0.37
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-23.21%
Return on equity-57.49%
Income (TTM)
Revenue0.00 USD
Gross profit-336.00K USD
EBITDA-41.60M USD
Net income-52.31M USD
Diluted EPS-$1.02
Rev. growth (YoY)0.00%
Balance sheet
Total cash65.86M USD
Total debt11.01M USD
Debt / equity16.56
Current ratio6.06
Book value / share$1.63
Cash flow (TTM)
Operating cash flow-36.44M USD
Levered free cash flow-18.07M USD
Shares & price
Shares outstanding40.85M
Float27.26M
Held by institutions44.30%
Beta-0.39
50-day MA$0.64
200-day MA$0.70
52-week high$1.83
52-week low$0.51
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-06-0.28-0.26+7.14%2026-04-30-0.28-0.14+50.00%2026-03-30-0.65-0.68−4.62%2026-03-13-0.34-0.27+20.59%
About Barinthus Biotherapeutics Pte Ltd.

Barinthus Biotherapeutics Pte Ltd is a biotechnology company focused on pioneering advancements in biotherapeutic solutions to address unmet medical needs. Specializing in the development of novel therapies, Barinthus Biotherapeutics seeks to innovate beyond traditional biopharmaceuticals, targeting significant disease areas such as oncology and neurology. The company employs cutting-edge research techniques, including gene therapy and regenerative medicine, to develop treatments that may transform patient care and outcomes. As part of the broader biotech sector, Barinthus Biotherapeutics plays an integral role in pushing the boundaries of medical research and development. Its contributions are crucial in driving the biopharmaceutical industry's growth through the discovery and application of new treatment modalities. With a commitment to scientific excellence and patient-focused innovation, Barinthus Biotherapeutics aims to deliver groundbreaking therapies that could redefine standards in medical treatment.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. William James Enright MBA
Employees
14
Headquarters
Germantown, MD, United States

Frequently asked questions about Barinthus Biotherapeutics Pte Ltd.